Medtronic (MDT) Gains from Investment Securities (2014 - 2026)

Medtronic has disclosed Gains from Investment Securities across 13 years of filings, most recently posting $1.8 billion for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $1.8 billion, up 230.84% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.9 billion (up 263.48% YoY), and the FY2025 annual result was $249.0 million, down 4.6% from the prior year.
• Gains from Investment Securities came in at $1.8 billion for Q1 2026 at Medtronic, up from -$292.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $1.8 billion in Q1 2026 to a low of -$1.4 billion in Q1 2024.
• The 5-year median for Gains from Investment Securities is $154.0 million (2022), against an average of $269.0 million.
• Across the five-year window, Gains from Investment Securities tumbled 3944.12% in 2024 and soared 1288.89% in 2025, its largest moves.
• Medtronic's Gains from Investment Securities stood at -$408.0 million in 2022, then soared by 343.38% to $993.0 million in 2023, then jumped by 33.53% to $1.3 billion in 2024, then slumped by 122.02% to -$292.0 million in 2025, then soared by 704.45% to $1.8 billion in 2026.
• The last three Gains from Investment Securities figures came in at $1.8 billion (Q1 2026), -$292.0 million (Q4 2025), and $125.0 million (Q3 2025), per Business Quant data.